Starpharma Holdings Limited SPHRY
3.25 USD 0.00 0.00%
At close · Oct 30
- YTD
- +33.74%
- 1 year
- +43.17%
- Open
- 3.02
- Prev close
- 3.25
- Mkt cap
- 136.87M
- Vol
- 1.10K
- Avg vol
- 945
- EPS
- -0.11921
- P/E
- -27.26
More statistics
- Low
- 3.02
- High
- 3.25
MAX chart
Chart tools
Chart is warming up
The all-time price history for SPHRY has not been loaded yet. Try again in a moment.
Altman Z-Score
1.22 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
P/E -38.1×
P/S 24.1×
P/B 20.6×
P/FCF -81.2×
EV/EBITDA -15.3×
EV/Sales 23.2×
FCF Yield -1.2%
Gross Margin 86.3%
Operating Margin -159.6%
Net Margin -62.0%
ROE -53.0%
ROIC -51.8%
ROA -38.4%
Revenue 101.5%
Operating Income 14.8%
EPS (diluted) 27.6%
Free Cash Flow 48.6%
Current Ratio 3.4×
Quick Ratio 3.1×
Debt / Equity 0.1×
Net Debt / EBITDA 0.6×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-06-30